NKGen Biotech (NKGN) Financial Statements

122 Followers

NKGen Biotech Financial Overview

NKGen Biotech's market cap is currently $261.20K. The company's EPS TTM is $-1.03; its P/E ratio is >-0.01; NKGen Biotech is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 77.00K	$ 426.00K
Gross Profit	$ 0.00	$ 0.00	$ 59.00K	$ 396.00K
Operating Income	$ -26.97M	$ -29.75M	$ -24.35M	$ -21.86M
EBITDA	$ -40.19M	$ -81.00M	$ -23.23M	$ -20.70M
Net Income	$ -44.29M	$ -82.95M	$ -26.75M	$ -23.27M
Balance Sheet
Cash & Short-Term Investments	$ 0.00	$ 26.00K	$ 117.00K	$ 351.00K
Total Assets	$ 24.00K	$ 16.48M	$ 16.33M	$ 18.07M
Total Debt	$ 0.00	$ 19.92M	$ 12.03M	$ 51.97M
Net Debt	$ 0.00	$ 19.89M	$ 11.92M	$ 51.62M
Total Liabilities	$ 0.00	$ 75.17M	$ 14.77M	$ 56.12M
Stockholders' Equity	$ 0.00	$ -58.69M	$ 1.56M	$ -38.05M
Cash Flow
Free Cash Flow	$ -20.88M	$ -22.00M	$ -22.72M	$ -20.01M
Operating Cash Flow	$ -20.88M	$ -21.95M	$ -22.56M	$ -19.55M
Investing Cash Flow	$ -13.00K	$ -48.00K	$ -163.00K	$ -459.00K
Financing Cash Flow	$ 20.85M	$ 22.16M	$ 22.49M	$ 20.16M

Currency in USD

NKGen Biotech Earnings and Revenue History

Income Statement >

NKGen Biotech Debt to Assets

Balance Sheet >

NKGen Biotech Cash Flow

Cash Flow >

NKGen Biotech Forecast EPS vs Actual EPS

Earnings >